Pharmacoflash 14 : Oncology (1)

16:15 • 353 • Asciminib CSF distribution: a case report > N. Nicolas Vignal 16:21 • 689 • Beyond the 0.1 µM Threshold: Real-World Variability in High-Dose Methotrexate Elimination under Standardized Protocols > L. LARRY LEIVA 16:27 • 584 • Pre-Therapeutic DPD Phenotyping in Predicting Fluoropyrimidine-Related Toxicity in Tunisian Cancer Patients 16:33 • 76 • Factors Associated With Immune-Related Adverse Events and Development of a Prediction Model in Patients With Malignant Tumors > W. Weibin Fan 16:45 • 149 • Measuring the Unmeasurable: Tucatinib Exposure in Plasma, CSF and Brain Tumor Tissue > M. Manon LAUNAY 16:51 • 142 • Central nervous system exposure to imatinib in pediatric and young adult acute lymphoblastic leukemia: Pharmacokinetics and clinical implications > A. Anna Sofie Buhl Rasmussen